| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | Director | Common Stock | 192K | $3.04M | $15.84 | Aug 18, 2025 | Direct |
| Syndax Pharmaceuticals Inc | Director | Stock Options (Right to buy) | 0 | Aug 18, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | Aug 14, 2025 | 10 | -$460K | 4 | Aug 18, 2025 | Director |
| SNDX | Syndax Pharmaceuticals Inc | Feb 5, 2025 | 1 | $0 | 4 | Feb 7, 2025 | Director |
| SNDX | Syndax Pharmaceuticals Inc | Feb 7, 2024 | 1 | $0 | 4 | Feb 9, 2024 | Director |
| SNDX | Syndax Pharmaceuticals Inc | Feb 2, 2023 | 1 | $0 | 4 | Feb 3, 2023 | Director |
| SNDX | Syndax Pharmaceuticals Inc | Sep 15, 2022 | 9 | -$1.4M | 4 | Sep 16, 2022 | Director |
| SNDX | Syndax Pharmaceuticals Inc | Feb 2, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Director |
| SNDX | Syndax Pharmaceuticals Inc | Oct 5, 2021 | 1 | $0 | 4 | Oct 6, 2021 | Director |